ELTP Alerts 08/16/2014 11:30:03 $ELTP Unfortunately that

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
ELTP Alerts 08/16/2014 11:30:03 $ELTP
Unfortunately that is not true. Perhaps one should read the FDA approved statement:

The naltrexone component was shown to have degraded to unacceptable degrees in samples of Embeda that were tested, Pfizer said. The problem is unlikely to pose a safety risk and patients can continue taking the drug as prescribed, the drugmaker said.


Seems there are new partners involved now too. speculation is J&J as well as Actavis. Product is modular so you are looking at a several billion dollar buyout. This is the most likely end game with Elite. Just a matter of when it happens. The further along this goes, the higher the price goes.
Yes, because we were/are holding out until OUR terms are met. That way all shareholders get the best deal possible.
Why am I not surprised to hear complaints that Elite is growing and see's a need for expansion? Ooh the horror! They must be doing pretty poorly to need additional space? It's not like the company is in its strongest financial shape ever, it's not like the CEO, BOD, and employee's whom are compensated partially with shares care about the share structure. It's not like we are ramping up to enter a market worth BILLIONS, or have modular technology that once one ADT product is approved, others will follow in rapid succession.

Clearly, we should all sell and move to Houston, plant a couple pecan trees and wait for the nuts to arrive. ...if they are not already here.

Very Bullish $ELTP


Here's what people need to know when it comes to investing:


-Hindsight is 20/20.

-Long term investors ALWAYS outperform traders.

-Traders ALWAYS lose.

-The greatest investor of ALL TIME follows the long term approach.


Have a great day everyone.
No it's completely UN-predictable.

HINDSIGHT IS 20/20.

I've followed this message board for over 3 years and read every message and EVERYONE HAS BEEN COMPLETELY WRONG ABOUT EVERYTHING


Bad idea to buy, hold, accumulate if you are in penny stocks; good way of going broke. Good idea to flip ELTP because it really is so predictable.
Bad idea.

It's a proven fact you make more money by never selling.

Ask Warren Buffett - The greatest investor of all time.

Also, it's a proven fact that all females outperform all males when it comes to investing. WHY? - Because THEY NEVER SELL!!!!!!!!!

This is why I will never sell and is why I currently have and will continue to make more money than everyone on this board who trades!!!!!!!!!

It's a proven fact that traders underperform the market and underperform ELTP.

All who have tried to trade stocks ALWAYS GET BURNED.

Warren Buffett - "Our favorite holding period is FOREVER".
Hmmmmmmmm!!!!!!! It has been reloading time and now it is time to actively wait for flipping opportunity creation and the ceremonious dumping of shares in the rinse repeat fashion. This has been the most consistent thing about ELTP over the past 3 years. I too am waiting to activate my FlipperMe alias.
Remember last year at the R and R conference Nasrat said "there are a lot of partners".

Here we are 1 YEAR LATER, STILL NO PARTNERS!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Quote:
partnership talks underway

Why do you care if a run is coming????

You said you were a long term investor.
The question was not that Isradipine existed or didn't exist. It was that it should have launched by now and didn't courtesy of CEO who believes generics are bread crumbs but yet dumped 12 of the bread crumb producers on JT for a hefty $10M. No wonder CEO does his best to hype ELTP with his substantiated and undocumented protocols for evaluations, his own, and the mysterious evaluation company.

I do sense that hype is losing its edge; it is not producing like before. Wonder why? Could it be the millions upon millions of new shares in the A/S. I am told that there are 995,000,000 shares. Complicating this fact is the new "oh by the way" there is a 20,000sf addition in the pipeline that could cost millions more in shares. The irony is that Elite already has two facilities which were supposed to accommodate the ART; that 11 ANDA generics were farmed out to Epic. Incidentally the one not farmed out is the one that Elite said it couldn't produce then decided in could produce and hasn't produced to date.
Indeed good sir.....yes indeed Elite has come along way and the DD Longs saw what was coming from a long ways away and let no disturbance detract from gathering shares on the cheap. You and I both know the next run is gearing up and is coming.....you have picked up additional shares recently and I am playing the Bear Raid and sell the news mentality.

This is why you pick up shares below .35.....yes indeed the RUN is coming and we both know it!! $$$$$
Quote:
1) Pursuant to the terms and conditions of the Modified 135 Ludlow Lease, the Company is permitted to use the entire 35,000 square feet in the building located at 135-137 Ludlow Avenue for the storage of pharmaceutical finished goods, raw materials, equipment and documents as well as engaging in manufacturing, packaging and distribution activities.

Prior to the Modified 135 Ludlow Lease, the Company occupied only 15,000 square feet at the 135 Ludlow location. The Modified 135 Ludlow Lease accordingly represents a significant expansion in the size of the Northvale Facility.

2) Research and development costs for the three months ended June 30, 2014 were $4,020k, an increase of $3,451k or approximately 607% from $238k of such costs for the comparable period of the prior year. The increase was primarily due to increased activities related to the development of Elite’s abuse resistant opioid products.

3) The Company believes that the successful resolution of the monetary bond defaults will have a significant and positive effect on the Company’s operations.

Yes that does sound quite familiar. Good thing I listened to my gut just like I am now.

No more going concern, bond debt issue gone, partnership talks underway, NDA on track to be filed by years end....
Yeah just like ELTP was no good at .125 and the Mountain of cries for selling came and went like a hill of manure.
LMAO "If they exist at all" ....thats a good one.....so what is going to be said when Isradipine is launched??? Heard the same misinformation when the stock was at .06 and Elite was waiting on Methadone to launch.

Problem is all the antihype is being left in the dust. No more going concern and clearing up the bond debt issue.
Quote:
The significant increase in revenues is due to the continued growth and expansion of Elite’s generic product lines

Please do tell. What is happening on all the opioids besides being acclaimed into the pipeline. Yes I know, they are just in the pipeline.
Noticed that the revenue clip was removed and probably for good reason. There is not much there compared to the expenditures and we don't want to call attention to that. We also didn't mention the potential of additional dilution to pay for the dream 20,000sf addition that is designed to produce the 11 ANDAs that Epic will be doing for the substantial cut nor does it say what the current facilities, intended to take care of generics and ART, will be dedicated to. Oh don't say, they will continue producing the 8 generics.
Oh! Is there doubt? Should there be after all CEO said so! CEO said $5.00 then it must be $5.00.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 3

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 4

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 3

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 3

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 3

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 3

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 3

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 3

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 3

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 4

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading

Top 5 Most Recently Viewed Articles

Vanguard and US Bank Regulator Agree on Control Measures

Updated Category News Views 529

Vanguard and Its Agreement with US Bank Regulators Recently, Vanguard has reached a notable agreement with the Federal Deposit Insurance Corporation (FDIC). This arrangement, known as a passivity agreement, reflects Vanguard's commitment to maintain stability and transparency in its operations concerning bank stakes. Understanding the Passivity Agreement So, what does...

Continue Reading
Monday.com Faces Analyst Optimism Amid Price Target Adjustments

Updated Category News Views 179

Monday.com Reports Impressive Q2 Results Monday.com Ltd. (NASDAQ: MNDY) has recently announced its financial performance for the second quarter, showcasing a noteworthy increase in revenue. The company achieved a revenue figure of $299 million, reflecting a remarkable 27% year-on-year growth. This surge is largely attributed to heightened demand from enterprise customers...

Continue Reading
Golden Ocean and CMB.TECH: Key Update on Trading Status

Updated Category News Views 197

Important Update on Golden Ocean and CMB.TECH Merger The Golden Ocean Group Limited (NASDAQ: GOGL), a key player in the shipping industry, recently announced vital timelines for the completion of its merger with CMB.TECH NV (NYSE: CMBT). This significant change is making waves in the stock trading community, with important implications for shareholders. Final Trading Day...

Continue Reading
Garanti Bankasi Unveils New Capital Markets Instrument Note

Updated Category News Views 128

Garanti Bankasi Introduces Capital Markets Instrument Note Garanti Bankasi (IS:GARAN) A.S., a leading Turkish financial institution, proudly announced the approval of its new Capital Markets Instrument Note. This important step has been sanctioned by the crucial regulatory body, the Capital Markets Board, marking a pivotal point in the bank's financial operations....

Continue Reading
Analyzing Market Trends Surrounding Chipotle Mexican Grill

Updated Category News Views 135

Understanding Chipotle Mexican Grill's Short Interest Dynamics Chipotle Mexican Grill's (NYSE: CMG) short percent of float has seen a significant decrease of 9.76% since the last report. This drop indicates a total of 24.63 million shares sold short, which represents about 1.85% of all the shares available for trading. With current trading volume trends, it would take...

Continue Reading